Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Antibe's Stomach-Friendly NSAID Keeps Chugging Along
View:
Post by Free55dom on Apr 02, 2021 1:05pm

Antibe's Stomach-Friendly NSAID Keeps Chugging Along

Phase 3 trials in Canada before even the most preliminary toxicology studies are run in humans. But in this case, where a novel class of an analgesic/anti-inflammatory drug is sorely needed, whatever gets them there fastest is just fine. 

https://www.acsh.org/news/2021/03/31/antibes-stomach-friendly-nsaid-keeps-chugging-along-15442
Comment by Marky1 on Apr 02, 2021 3:53pm
I sent Dan the article...This is his reply.....Nice PR; a lot of mistakes in it!
Comment by Inthepez on Apr 03, 2021 12:03am
The biggest one is that otenaproxesul is not a pro-drug. That would denote that if take a handful of naproxen and a handful h2s, you’d get the same GI sparing effects. Obviously that’s not the case 
Comment by Marky1 on Apr 03, 2021 12:40am
I don't understand..Does the article say that otenaproxesul is a pro drug? I don't see that.. please clarify
Comment by themagicbox on Apr 03, 2021 10:48am
Pez is correct. Josh Bloom had a link to one of his previous articles (here:https://www.acsh.org/news/2020/03/01/huge-advance-pain-management-nsaid-without-gi-side-effects-clinic-14606) Where he makes several mistakes in the chemical structure of the compound and calls it a pro-drug. Good eye, pez.
Comment by RjM2018 on Apr 04, 2021 9:35pm
Inthepez - although Otena isn't a prodrug, your explanation of a prodrug  isn't incorrect. See Definition below. Ex: Vyvanse is a prodrug of adderall... Quote: "A pro-drug is a chemically modified structure of a known drug that is inactive until the active species is liberated by metabolism. ATB-346 is technically not a pro-drug since it breaks down to two active species ...more  
Comment by Inthepez on Apr 05, 2021 9:18am
My explanation is directly taken from Wallace’s presentation in 2017: https://m.youtube.com/watch?v=w_3heP7ol0A
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities